Skip to main content
Top
Published in: BMC Hematology 1/2018

Open Access 01-12-2018 | Research article

Risk factors of metabolic syndrome among adult Sudanese sickle cell anemia patients

Authors: Awab Omer Babiker, Lamis AbdelGadir Kaddam

Published in: BMC Hematology | Issue 1/2018

Login to get access

Abstract

Background

Sickle cell disease is a hereditary disorder characterized by haematological anaemia. Several studies assumed that adult sickle patients might develop metabolic syndrome features as hyperglycaemia, hypertension and dyslipidaemia. The aim of this study was to evaluate the metabolic syndrome risk factors among adult Sudanese with sickle cell anemia in the steady state.

Methods

A prospective cross sectional study design was conducted among thirty adult patients with sickle cell anemia Hb SS (mean age 23 ± 6.1 years) and thirty healthy individuals matched for age and gender. Waist and hip circumferences were measured by simple tape. Venous blood sample were analysed to detect blood glucose level, uric acid, total cholesterol, triglycerides, low and high-density lipoprotein after 8 h overnight fasting by spectrophotometer. Blood pressure was measured by sphygmomanometer. National Cholesterol Education Program-Adult Treatment Panel III was utilised to define metabolic syndrome. Statistical analysis was performed SPSS software version 23. Continuous data were expressed using mean ± SD. P-value of < 0.05 (two-tailed) was used to establish statistical significance. Unpaired independent T- test was used.

Results

No significant difference in mean systolic blood pressure in patients group compared to control (P value = 0.3). Mean value of diastolic blood pressure was significantly low in patients group compared to control (65.4 ± 10. 4 VS72.33 ± 8.27 mmHg, P value< 0.001). Fasting triglycerides level was comparable between patients group and control (P value = 0.56). While high-density lipoprotein was significantly lower in sicklers compared to control (30.2 ± 8.2 mg/dL vs 44.71 ± 1.85 mg/dL, P value< 0.001). Fasting blood glucose was significantly low in sickle compared to control (92.6 ± 13 mg/dL vs 106.83 ± 25.11 mg/dL P value< 0.001). Uric acid level was not statistically differed in patients group compared to control (p value = 0.5).

Conclusion

There was significant decrease in fasting High-density lipoprotein, diastolic blood pressure, mean arterial pressure and fasting blood glucose among SCA patients compared to control. There was no significant difference in waist circumference, systolic blood pressure, fasting triglycerides and uric acid levels between patients and control groups.
Literature
1.
go back to reference Zorca S, Freeman L, Hildesheim M, Allen D, Remaley AT, Taylor JG, et al. Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension. Br J Haematol [Internet]. 2010;149(3):436–445. Zorca S, Freeman L, Hildesheim M, Allen D, Remaley AT, Taylor JG, et al. Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension. Br J Haematol [Internet]. 2010;149(3):436–445.
2.
go back to reference Bediako SM, Nelson J, Cichowitz C, Yu T, Carroll CP, Stewart KJ, et al. Metabolic Syndrome Risk Among Adults Living with Sickle Cell Disease. Blood [Internet]. 2015;126(23). Bediako SM, Nelson J, Cichowitz C, Yu T, Carroll CP, Stewart KJ, et al. Metabolic Syndrome Risk Among Adults Living with Sickle Cell Disease. Blood [Internet]. 2015;126(23).
4.
go back to reference Uche A, et al. Correlates of Steady State Lipid Profile and Anthropometric Parameters in Adult Sickle Cell Anaemia Patients in South-West Nigeria. IOSR J Dent Med Sci [Internet]. 2017;16(2):76–81. Uche A, et al. Correlates of Steady State Lipid Profile and Anthropometric Parameters in Adult Sickle Cell Anaemia Patients in South-West Nigeria. IOSR J Dent Med Sci [Internet]. 2017;16(2):76–81.
5.
go back to reference Alsultan AI, Seif MA, Amin TT, Naboli M, Alsuliman AM. Relationship between oxidative stress, ferritin and insulin resistance in sickle cell disease. Eur Rev Med Pharmacol Sci [Internet]. 2010;14(6):527–538. Alsultan AI, Seif MA, Amin TT, Naboli M, Alsuliman AM. Relationship between oxidative stress, ferritin and insulin resistance in sickle cell disease. Eur Rev Med Pharmacol Sci [Internet]. 2010;14(6):527–538.
6.
go back to reference Oguanobi NI, Onwubere BJC, Ibegbulam OG, Ike SO, Anisiuba BC, Ejim EC, et al. Arterial blood pressure in adult Nigerians with sickle cell anemia. J Cardiol [Internet]. 2010;56(3):326–331. Oguanobi NI, Onwubere BJC, Ibegbulam OG, Ike SO, Anisiuba BC, Ejim EC, et al. Arterial blood pressure in adult Nigerians with sickle cell anemia. J Cardiol [Internet]. 2010;56(3):326–331.
7.
go back to reference Reynolds MD. Gout and hyperuricemia associated with sickle-cell anemia. Semin Arthritis Rheum [Internet]. 1983;12(4):404–13. Reynolds MD. Gout and hyperuricemia associated with sickle-cell anemia. Semin Arthritis Rheum [Internet]. 1983;12(4):404–13.
8.
go back to reference Hibbert JM, Hsu LL, Bhathena SJ, Irune I, Sarfo B, Creary MS, et al. Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease. Exp Biol Med (Maywood) [Internet]. 2005;230(1):68–74. Hibbert JM, Hsu LL, Bhathena SJ, Irune I, Sarfo B, Creary MS, et al. Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease. Exp Biol Med (Maywood) [Internet]. 2005;230(1):68–74.
9.
go back to reference Pikilidou M, Yavropoulou M, Antoniou M, Papakonstantinou E, Pantelidou D, Chalkia P, et al. Arterial stiffness and peripheral and central blood pressure in patients with sickle cell disease. J Clin Hypertens [Internet]. 2015;17(9):726–731. Pikilidou M, Yavropoulou M, Antoniou M, Papakonstantinou E, Pantelidou D, Chalkia P, et al. Arterial stiffness and peripheral and central blood pressure in patients with sickle cell disease. J Clin Hypertens [Internet]. 2015;17(9):726–731.
10.
go back to reference Pegelow CH, Colangelo L, Steinberg M, Wright EC, Smith J, Phillips G, et al. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med [Internet]. 1997;102(2):171–177. Pegelow CH, Colangelo L, Steinberg M, Wright EC, Smith J, Phillips G, et al. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med [Internet]. 1997;102(2):171–177.
11.
go back to reference Gladwin MT, Sachdev V. Cardiovascular abnormalities in sickle cell disease. J Am Coll Cardiol [Internet]. 2012;59(13):1123–1133. Gladwin MT, Sachdev V. Cardiovascular abnormalities in sickle cell disease. J Am Coll Cardiol [Internet]. 2012;59(13):1123–1133.
12.
go back to reference Ayuo PO, Abinya NA, Joshi MD, Lore W. Cardiovascular features in adolescents and adults with sickle cell anaemia. East Afr Med J. 1993;70(5):270–276. Ayuo PO, Abinya NA, Joshi MD, Lore W. Cardiovascular features in adolescents and adults with sickle cell anaemia. East Afr Med J. 1993;70(5):270–276.
13.
go back to reference Yavropoulou MP, Pikilidou M, Pantelidou D, Tsalikakis DG, Mousiolis A, Chalkia P, et al. Insulin secretion and resistance in Normoglycemic patients with sickle cell disease. Hemoglobin [Internet]. 2017;41(1):6–11. Yavropoulou MP, Pikilidou M, Pantelidou D, Tsalikakis DG, Mousiolis A, Chalkia P, et al. Insulin secretion and resistance in Normoglycemic patients with sickle cell disease. Hemoglobin [Internet]. 2017;41(1):6–11.
14.
go back to reference Henriksen EJ, Diamond-Stanic MK, Marchionne EM. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med [Internet]. 2011;51(5):993–999. Henriksen EJ, Diamond-Stanic MK, Marchionne EM. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med [Internet]. 2011;51(5):993–999.
15.
go back to reference Essohana P, Irenee K, Delagnon M, Lochina F, Hezouwe M, Koffi M, et al. Cholesterol and Triglyceride Levels in Patients with Homozygous Sickle Cell Disease at Campus Teaching Hospital of Lomé (Togo). Sci J Clin Med [Internet]. 2016;5(2):24–8. Essohana P, Irenee K, Delagnon M, Lochina F, Hezouwe M, Koffi M, et al. Cholesterol and Triglyceride Levels in Patients with Homozygous Sickle Cell Disease at Campus Teaching Hospital of Lomé (Togo). Sci J Clin Med [Internet]. 2016;5(2):24–8.
16.
go back to reference Ephraim RKD, Adu P, Ake E, Agbodzakey H, Adoba P, Cudjoe O, et al. Normal Non-HDL Cholesterol, Low Total Cholesterol, and HDL Cholesterol Levels in Sickle Cell Disease Patients in the Steady State: A Case-Control Study of Tema Metropolis. J Lipids [Internet]. 2016;2016:1–5. Ephraim RKD, Adu P, Ake E, Agbodzakey H, Adoba P, Cudjoe O, et al. Normal Non-HDL Cholesterol, Low Total Cholesterol, and HDL Cholesterol Levels in Sickle Cell Disease Patients in the Steady State: A Case-Control Study of Tema Metropolis. J Lipids [Internet]. 2016;2016:1–5.
17.
go back to reference Garvey WT, Maianu L, Zhu JH, Brechtel-Hook G, Wallace P, Baron AD. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest [Internet]. 1998;101(11):2377–2386. Garvey WT, Maianu L, Zhu JH, Brechtel-Hook G, Wallace P, Baron AD. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest [Internet]. 1998;101(11):2377–2386.
18.
go back to reference Wt G, Maianu L, Zhu J-H, Brechtel-Hook G, Wallace P, Baron AD. Evidence for defects in the trafficking and translocation of GLUT 4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest. 1998;101:2377–86. Wt G, Maianu L, Zhu J-H, Brechtel-Hook G, Wallace P, Baron AD. Evidence for defects in the trafficking and translocation of GLUT 4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest. 1998;101:2377–86.
19.
go back to reference Rothschild BM, Sienknecht CW, Kaplan SB, Spindler JS. Sickle cell disease associated with uric acid deposition disease. Ann Rheum Dis [Internet]. 1980;39(4):392–395. Rothschild BM, Sienknecht CW, Kaplan SB, Spindler JS. Sickle cell disease associated with uric acid deposition disease. Ann Rheum Dis [Internet]. 1980;39(4):392–395.
20.
go back to reference Al-Naama LM, al-Sadoon EA, al-Sadoon TA. Levels of uric acid, urea and creatinine in Iraqi children with sickle cell disease. J Pak Med Assoc [Internet]. 2000;50(3):98–102. Al-Naama LM, al-Sadoon EA, al-Sadoon TA. Levels of uric acid, urea and creatinine in Iraqi children with sickle cell disease. J Pak Med Assoc [Internet]. 2000;50(3):98–102.
21.
go back to reference Cerqueira BAV, Boas W V., Zanette AD, Reis MG, Goncalves MS. Increased concentrations of IL-18 and uric acid in sickle cell anemia: contribution of hemolysis, endothelial activation and the inflammasome. Cytokine [Internet]. 2011;56(2):471–476. Cerqueira BAV, Boas W V., Zanette AD, Reis MG, Goncalves MS. Increased concentrations of IL-18 and uric acid in sickle cell anemia: contribution of hemolysis, endothelial activation and the inflammasome. Cytokine [Internet]. 2011;56(2):471–476.
Metadata
Title
Risk factors of metabolic syndrome among adult Sudanese sickle cell anemia patients
Authors
Awab Omer Babiker
Lamis AbdelGadir Kaddam
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Hematology / Issue 1/2018
Electronic ISSN: 2052-1839
DOI
https://doi.org/10.1186/s12878-018-0110-7

Other articles of this Issue 1/2018

BMC Hematology 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.